Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2006 | |
| Sales | 30,173 | 12,379 | 19,210 | 0 | 0 |
| Cost of Goods | 7,829 | 5,104 | 6,436 | N/A | N/A |
| Gross Profit | 22,344 | 7,276 | 12,775 | N/A | N/A |
| Operating Expenses | 102,525 | 88,747 | 52,760 | 0 | 0 |
| Operating Income | -79,352 | -81,368 | -39,549 | N/A | N/A |
| Interest Expense | 6,144 | 3,419 | 2,235 | 0 | 0 |
| Other Income | -18,480 | -3,487 | -6,703 | 0 | 0 |
| Pre-tax Income | -103,976 | -88,273 | -48,487 | 0 | 0 |
| Income Tax | -11,380 | -4,696 | -4,024 | N/A | N/A |
| Net Income Continuous | -92,596 | -83,577 | -44,463 | N/A | N/A |
| Minority Interests | -7,949 | -7,448 | -4,560 | N/A | N/A |
| Net Income | $-84,647 | $-76,130 | $-39,903 | $N/A | $N/A |
| EPS Basic Total Ops | -1,200.00 | -1,283.80 | -705.00 | N/A | N/A |
| EPS Basic Continuous Ops | -1,353.83 | -1,396.70 | -778.89 | N/A | N/A |
| EPS Diluted Total Ops | -1,200.00 | -1,283.80 | -705.00 | N/A | N/A |
| EPS Diluted Continuous Ops | -1,353.83 | -1,396.70 | -778.89 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1,200.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-75,822 | $-78,913 | $-37,641 | $N/A | $N/A |